Published in J Surg Res on August 05, 2015
Discovery and development of natural product oridonin-inspired anticancer agents. Eur J Med Chem (2016) 0.77
STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis. RSC Adv (2016) 0.75
Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound. Int J Mol Sci (2016) 0.75
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Liver fibrosis. J Clin Invest (2005) 17.27
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93
Non-Smad TGF-beta signals. J Cell Sci (2005) 6.06
Roles of TGF-beta in hepatic fibrosis. Front Biosci (2002) 4.15
Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity (2007) 3.61
Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol (2011) 2.82
HIV-1 adaptation to NK-cell-mediated immune pressure. Nature (2011) 2.59
Evolving therapies for liver fibrosis. J Clin Invest (2013) 2.59
Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30
New aspects of natural products in drug discovery. Trends Microbiol (2007) 2.06
Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther (2002) 1.94
Hepatic stellate cells and liver fibrosis. Compr Physiol (2013) 1.75
Pathobiology of liver fibrosis: a translational success story. Gut (2015) 1.72
Hepatic fibrosis: Concept to treatment. J Hepatol (2015) 1.68
Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology (2002) 1.62
The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch (1997) 1.54
Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization. J Cell Biol (2008) 1.53
Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol (2008) 1.23
Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Front Physiol (2012) 1.20
Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2. In Vitro Cell Dev Biol (1989) 1.19
Cellular basis of hepatic fibrosis and its role in inflammation and cancer. Front Biosci (Schol Ed) (2013) 1.19
Origins and functions of liver myofibroblasts. Biochim Biophys Acta (2013) 1.13
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells. Int J Oncol (2011) 1.10
Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys (2014) 1.08
Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility. J Med Chem (2013) 1.06
Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule. Am J Pathol (2007) 0.93
Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis. J Med Chem (2013) 0.92
Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma. Acta Pharmacol Sin (2006) 0.92
Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J Gastroenterol Hepatol (2012) 0.91
Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis. J Surg Res (2014) 0.89
Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. Int Immunopharmacol (2009) 0.87
Oridonin: targeting programmed cell death pathways as an anti-tumour agent. Cell Prolif (2012) 0.87
Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells. Adv Pharmacol Sci (2014) 0.86
Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position. Org Lett (2013) 0.86
Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique. Int J Pharm (2011) 0.84
ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids. Org Biomol Chem (2014) 0.84
Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin. Chin J Integr Med (2013) 0.82
Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases. Cytotechnology (2013) 0.82
Synergistic effect of natural compounds on the fatty acid-induced autophagy of activated hepatic stellate cells. J Nutr Biochem (2014) 0.81